Data Sciences
Contract Research
Information
Modern biomarker-driven programs generate massive volumes of data, both in the lab and the clinic throughout the course of development. At Precision, we understand how valuable this data is, and how the “right” data can lead you to insights that transform your program and profoundly impact patient health. This is why we take a data-first approach to every therapeutic and diagnostic development program.
Data-first is transformative as data becomes an asset rather than a challenge. Data-first empowers insights that can guide every facet of drug development from biomarker identification to indication selection to site selection. And data-first provides the visibility that is necessary to operate effectively on a global scale.
Precision reaches across information silos, fusing disparate data and adding expertise to spark insight, drive decision making, and accelerate development
